Continuing Medical Education

Novel Applications for Bevacizumab
and Other Angiogenic Inhibitors

New CME-certified program on novel and emerging uses of bevacizumab and other antiangiogenics for patients with glioma. In this activity, healthcare professionals will learn how and why researchers are exploring the more extensive use of antiangiogenic therapy. This half-hour activity will supplement your current knowledge about this difficult-to-treat disease.

NOVEL APPLICATIONS FOR BEVACIZUMAB AND OTHER
ANGIOGENIC INHIBITORS

[gobuzz.netstride.com]
Release Date: July 6, 2010 * Expiration Date: July 6, 2011

Click here to start the program: http://www.gliomaed.com/programs.asp?ProductID=83&audience=&Preview=true